Tag: dr anand srivastava

Editorial: Mesenchymal stem cells may be a credible alternative therapy to fight with COVID-19 pandemic Drs. Anand Srivastava, Prabhat Soni - GIOSTAR

Editorial: Mesenchymal stem cells may be a credible alternative therapy to fight with COVID-19 pandemic

Drs. Anand Srivastava and Prabhat Soni write in a medical journal on the potential benefits of stem cells in fighting against COVID-19. GIOSTAR recently received FDA Approval Under Compassionate Use to treat COVID-19 patients under compassionate use.

GIOSTAR Speaks with Dr. Amy Killen on Their Efforts to Treat COVID-19 with Stem Cells GIOSTAR Talks to Dr. Amy Killen About COVID-19 and Stem Cells

GIOSTAR Speaks with Dr. Amy Killen on Their Efforts to Treat COVID-19 with Stem Cells

GIOSTAR Co-Founders Dr. Anand Srivastava and Deven Patel recently spoke with Dr. Amy Killen about the company's ongoing research efforts related to coronavirus (COVID-19). Dr. Anand explains in great detail the mechanisms underlying the disease, including cytokine storms and the potential immunomodulatory benefits of mesenchymal [...]
GIOSTAR Webinar: Dr. Anand Srivastava on Treating COVID-19 with Stem Cells GIOSTAR Webinar | Dr. Anand Srivastava | Stem Cells, COVID-19

GIOSTAR Webinar: Dr. Anand Srivastava on Treating COVID-19 with Stem Cells

Dr. Anand Srivastava, Chairman and Co-Founder of GIOSTAR, speaks with Evan DeMarco, Janna Breslin, and the GIOSTAR Mexico team about the potential for stem cells in combatting COVID-19.   Related Resources GIOSTAR Speaks with Dr. Amy Killen on Their Efforts to Treat COVID-19 with Stem [...]
GIOSTAR Reviews Potential Benefits of Stem Cell Therapy on Coronavirus covid-19

GIOSTAR Reviews Potential Benefits of Stem Cell Therapy on Coronavirus

Since its outbreak, coronavirus (COVID-19) has cast an unprecedented impact that has reverberated throughout the world. Scientists, government officials, and doctors have searched frantically for a remedy, to help contain further disruption. In this video, GIOSTAR Co-Founder and Chairman Dr. Anand Srivastava reports on a study examining [...]
GIOSTAR In Process of US FDA Approval for Type 2 Diabetes Clinical Trial AdobeStock

GIOSTAR In Process of US FDA Approval for Type 2 Diabetes Clinical Trial

For more than two decades, Dr. Anand Srivastava and GIOSTAR have been at the forefront of stem cell therapy and research. The company is currently in process of FDA approval for groundbreaking clinical trials regarding Type 2 Diabetes, which impacts roughly 1 in 10 Americans.